Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/1/25 → 12/1/25 |
Funding
- Sanofi Pasteur Incorporated: $2.00
VAD00004 Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers
- Hicar, Mark (PI)
Project: Research